BIOGEN INC's ticker is and the CUSIP is 09062X953. A total of 9 filers reported holding BIOGEN INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $923,000 | -61.6% | 3,400 | -61.4% | 0.04% | +105.9% |
Q1 2017 | $2,406,000 | +182.7% | 8,800 | +193.3% | 0.02% | +325.0% |
Q4 2016 | $851,000 | -85.4% | 3,000 | -83.9% | 0.00% | -85.7% |
Q3 2016 | $5,822,000 | -68.7% | 18,600 | -75.8% | 0.03% | -67.8% |
Q2 2016 | $18,572,000 | +46.8% | 76,800 | +58.0% | 0.09% | +42.6% |
Q1 2016 | $12,652,000 | -11.6% | 48,600 | +4.1% | 0.06% | -12.9% |
Q4 2015 | $14,307,000 | -76.8% | 46,700 | -77.9% | 0.07% | -72.5% |
Q3 2015 | $61,601,000 | -7.2% | 211,100 | +28.5% | 0.26% | -14.4% |
Q2 2015 | $66,367,000 | -13.1% | 164,300 | -9.1% | 0.30% | -13.6% |
Q1 2015 | $76,341,000 | +131.4% | 180,800 | +86.0% | 0.34% | +159.4% |
Q4 2014 | $32,995,000 | -21.8% | 97,200 | -23.8% | 0.13% | -23.6% |
Q3 2014 | $42,211,000 | +14.4% | 127,600 | +9.1% | 0.17% | +4.2% |
Q2 2014 | $36,891,000 | -29.2% | 117,000 | -31.3% | 0.17% | -24.1% |
Q1 2014 | $52,090,000 | +49.5% | 170,300 | +36.7% | 0.22% | +77.4% |
Q4 2013 | $34,835,000 | +20.5% | 124,600 | +3.7% | 0.12% | +21.6% |
Q3 2013 | $28,915,000 | -23.9% | 120,100 | -32.0% | 0.10% | -26.6% |
Q2 2013 | $38,004,000 | – | 176,600 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Garda Capital Partners LP | 2,800 | $719,628 | 0.03% |
SIMPLEX TRADING, LLC | 110,700 | $28,451 | 0.02% |
GROUP ONE TRADING, L.P. | 20,500 | $5,268,705 | 0.02% |
JANE STREET GROUP, LLC | 79,700 | $20,483,697 | 0.01% |
Maven Securities LTD | 2,000 | $514,020 | 0.01% |
IMC-Chicago, LLC | 11,800 | $3,032,718 | 0.00% |
Allianz Asset Management GmbH | 5,200 | $1,336,452 | 0.00% |
JPMORGAN CHASE & CO | 44,000 | $11,308,440 | 0.00% |
SG Americas Securities, LLC | 11,900 | $76 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |